Takeda Pharmaceutical (TAK) FCF Margin Growth (3y) (2021 - 2026)
Takeda Pharmaceutical (TAK) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 253.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1,444.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,941.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,671.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,067.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -42,016.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 895.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 830.00 |
| 10 | Takeda Pharmaceutical | 169,609.19 | -6.60 Bn | 4.39 Bn | -1,107.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,107.00 |
| Dec 31, 2025 | 36.00 |
| Sep 30, 2025 | -1,311.00 |
| Jun 30, 2025 | 940.00 |
| Mar 31, 2025 | 550.00 |
| Dec 31, 2024 | -78.00 |
| Sep 30, 2024 | -2,187.00 |
| Jun 30, 2024 | -186.00 |
| Mar 31, 2024 | -1,129.00 |
| Dec 31, 2023 | -1,057.00 |
| Sep 30, 2023 | -1,336.00 |
| Jun 30, 2023 | -801.00 |
| Mar 31, 2023 | 3,048.00 |
| Sep 30, 2022 | -3,785.00 |
| Jun 30, 2022 | -475.00 |
| Mar 31, 2022 | 87,207.00 |
| Dec 31, 2021 | 2,029.00 |
| Sep 30, 2021 | 3,122.00 |
| Jun 30, 2021 | 2,070.00 |
| Mar 31, 2021 | 1,789.00 |